1. Home
  2. SABS vs FAT Comparison

SABS vs FAT Comparison

Compare SABS & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • FAT
  • Stock Information
  • Founded
  • SABS 2014
  • FAT 2017
  • Country
  • SABS United States
  • FAT United States
  • Employees
  • SABS N/A
  • FAT N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • FAT Restaurants
  • Sector
  • SABS Health Care
  • FAT Consumer Discretionary
  • Exchange
  • SABS Nasdaq
  • FAT Nasdaq
  • Market Cap
  • SABS 31.2M
  • FAT 25.4M
  • IPO Year
  • SABS N/A
  • FAT 2017
  • Fundamental
  • Price
  • SABS $4.09
  • FAT $0.54
  • Analyst Decision
  • SABS Strong Buy
  • FAT Strong Buy
  • Analyst Count
  • SABS 3
  • FAT 1
  • Target Price
  • SABS $9.00
  • FAT $10.00
  • AVG Volume (30 Days)
  • SABS 203.1K
  • FAT 412.0K
  • Earning Date
  • SABS 11-13-2025
  • FAT 11-05-2025
  • Dividend Yield
  • SABS N/A
  • FAT N/A
  • EPS Growth
  • SABS N/A
  • FAT N/A
  • EPS
  • SABS N/A
  • FAT N/A
  • Revenue
  • SABS $114,698.00
  • FAT $574,143,000.00
  • Revenue This Year
  • SABS N/A
  • FAT N/A
  • Revenue Next Year
  • SABS N/A
  • FAT $7.74
  • P/E Ratio
  • SABS N/A
  • FAT N/A
  • Revenue Growth
  • SABS N/A
  • FAT N/A
  • 52 Week Low
  • SABS $1.00
  • FAT $0.36
  • 52 Week High
  • SABS $6.60
  • FAT $6.17
  • Technical
  • Relative Strength Index (RSI)
  • SABS 71.11
  • FAT 16.20
  • Support Level
  • SABS $3.68
  • FAT $0.36
  • Resistance Level
  • SABS $4.15
  • FAT $1.55
  • Average True Range (ATR)
  • SABS 0.31
  • FAT 0.16
  • MACD
  • SABS 0.04
  • FAT -0.08
  • Stochastic Oscillator
  • SABS 93.18
  • FAT 14.92

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: